KEAP1 and lung carcinoma: To determine whether mutations in KEAP1 are present in lung cancer tumors, we amplified and sequenced KEAP1 in 40 primary lung tumors (25 of which were paired with normal tissue samples) and 16 PF samples from lung cancer patients at Johns Hopkins Hospital.